UBRELVY
Allergan Pharmaceuticals International Limited
The mark consists of the word "UBRELVY" below two wavy lines, both of which generally begin above the "E" in "UBRELVY" and extend in opposite directions.
Mark For: UBRELVY® trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The mark consists of the word "UBRELVY" below two wavy lines, both of which generally begin above the "E" in "UBRELVY" and extend in opposite directions.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88185227 |
| Registration Number | 6075800 |
| Mark Literal Elements | UBRELVY |
| Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
| Mark Type | TRADEMARK |
| Standard Character Claim | No |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-05-01 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Law Office Assigned | L40 |
| Employee Name | FATHY, DOMINIC |
Timeline
| 2018-11-07 | Application Filed |
| 2019-01-25 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-01-25 | Status: Live/Pending |
| 2019-02-06 | Transaction Date |
| 2019-03-05 | Published |
| 2019-03-05 | Published for Opposition |
| 2020-01-22 | Date of First Use |
| 2020-01-22 | Date of Use In Commerce |
| 2020-05-01 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-06-09 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2020-06-09 | Trademark Registered |
| 2025-06-09 | Maintenance Early File Date |
| 2026-06-09 | Maintenance On Time Date |
| 2026-12-09 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  Allergan Pharmaceuticals International Limited |
| Address | Clonshaugh Business and Technology Park Coolock, Dublin 17 IRELAND D17E400 |
| Legal Entity Type | Private Company Limited By Shares (prc) |
| Legal Entity State | IRELAND |
Documents
 Drawing | JPEG | 2018-11-07 |
 TEAS RF New Application | MULTI | 2018-11-07 |
| Design Search Code Corr Project | XML | 2018-11-27 |
| Notation to File | XML | 2019-01-24 |
| XSearch Search Summary | XML | 2019-01-24 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-01-26 |
| Notice of Publication | XML | 2019-02-13 |
| Notification Of Notice of Publication | XML | 2019-02-13 |
| OG Publication Confirmation | XML | 2019-03-05 |
| Notice of Allowance | XML | 2019-04-30 |
| Extension of Time to File SOU | XML | 2019-10-28 |
| ITU Extension Approval | XML | 2019-10-30 |
| ITU Unit Action | MULTI | 2019-10-30 |
| Specimen | JPEG | 2020-04-06 |
| Statement of Use | MULTI | 2020-04-06 |
| ITU Unit Action | MULTI | 2020-04-21 |
| Notice of Acceptance of Statement of Use | XML | 2020-05-02 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-05-02 |
| Registration Certificate | 2020-06-09 |
Design Search Codes
| 26.17.05 | Bands, horizontal; Bars, horizontal; Horizontal line(s), band(s) or bar(s); Lines, horizontal |
| 261702 | Bands, wavy; Bars, wavy; Lines, wavy; Wavy line(s), band(s) or bar(s) |
| 261705 | Bands, horizontal; Bars, horizontal; Horizontal line(s), band(s) or bar(s); Lines, horizontal |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonia, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhidrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body. FIRST USE: 20200122. FIRST USE IN COMMERCE: 20200122
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| CC0000 | Color is not claimed as a feature of the mark. |
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2020-06-09 | |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2020-05-02 | |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2020-05-01 | |
| STATEMENT OF USE PROCESSING COMPLETE | 2020-04-20 | 71906 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-04-20 | 71906 |
| USE AMENDMENT FILED | 2020-04-06 | 71906 |
| TEAS STATEMENT OF USE RECEIVED | 2020-04-06 | |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-10-30 | |
| TEAS EXTENSION RECEIVED | 2019-10-28 | |
| EXTENSION 1 GRANTED | 2019-10-28 | 98765 |
| EXTENSION 1 FILED | 2019-10-28 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-04-30 | |
| PUBLISHED FOR OPPOSITION | 2019-03-05 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-03-05 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-02-13 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-01-25 | |
| ASSIGNED TO EXAMINER | 2019-01-24 | 81854 |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2018-11-27 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-11-24 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-11-10 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 UBRELVY 88185227 not registered Live/Pending |
Allergan Pharmaceuticals International Limited 2018-11-07 |
 UBRELVY 88155130 not registered Live/Pending |
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED 2018-10-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 